S0174 HCPCS Level II code: Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)
S0174 is the HCPCS code for “Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
S0174Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)
Short description: Dolasetron 50 mg
HCPCS · United States
Notes for S0174
As CMS prints them, with any note S0174 takes from the headings above it.
Note
- CMS processing note 0088: "S" CODES ARE UNIQUE TEMPORARY CODES ESTABLISHED BY BCBSA AND HIAA FOR PRIVATE PAYOR USE. THEY ARE NOT VALID NOR PAYABLE BY MEDICARE.
Medicare details
The indicators CMS publishes with S0174 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Not payable by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Other medical items or services
- BETOS category
- Undefined codes
- Added
- Jan 1, 2002
Where S0174 sits
- 1S codesTemporary national codes (non-Medicare)
- 2Active code S0174Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code S0174 mean?
S0174 is the HCPCS code for “Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover S0174?
CMS lists S0174’s Medicare coverage as “Not payable by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside S0174
All S codesS0164Injection, pantoprazole sodium, 40 mgS0166Injection, olanzapine, 2.5 mgS0169Calcitrol, oral, 0.25 microgramS0170Anastrozole, oral, 1 mgS0171Injection, bumetanide, 0.5 mgS0172Chlorambucil, oral, 2 mgS0175Flutamide, oral, 125 mgS0176Hydroxyurea, oral, 500 mgS0177Levamisole hydrochloride, oral, 50 mgS0178Lomustine, oral, 10 mgS0179Megestrol acetate, oral, 20 mgS0182Procarbazine hydrochloride, oral, 50 mg